NCT06290518View on ClinicalTrials.gov

Modulation of Reproductive Microbiota by Ligilactobacillus Salivarius CECT5713

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

May 3, 2023

Study Completion Date

January 29, 2024

Conditions
Infertility Unexplained
Interventions
DIETARY_SUPPLEMENT

Ligilactobacillus salivarius CECT5713

Oral administration of a capsule containing 9.5 log10 cfu of the strain.

DIETARY_SUPPLEMENT

Placebo

Oral administration of a capsule containing maltodextrin.

Trial Locations (3)

18004

Biosearch S.A.U., Granada

28040

Hospital Clínico San Carlos, Madrid

Universidad Complutense de Madrid, Madrid

All Listed Sponsors
collaborator

Hospital San Carlos, Madrid

OTHER

collaborator

Universidad Complutense de Madrid

OTHER

lead

Biosearch S.A.

INDUSTRY

NCT06290518 - Modulation of Reproductive Microbiota by Ligilactobacillus Salivarius CECT5713 | Biotech Hunter | Biotech Hunter